Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Colorectal Neoplasms 64Head and Neck Neoplasms 63Squamous Cell Carcinoma of Head and Neck 60Carcinoma, Non-Small-Cell Lung 34Rectal Neoplasms 23Colonic Neoplasms 23Neoplasm Metastasis 19Neoplasms 18Carcinoma, Squamous Cell 17Pancreatic Neoplasms 13Lung Neoplasms 13Esophageal Neoplasms 11Tongue Neoplasms 9Stomach Neoplasms 9Recurrence 9Carcinoma 8Neoplasms, Squamous Cell 6Mouth Neoplasms 6Laryngeal Neoplasms 6Breast Neoplasms 6Adenocarcinoma Of Esophagus 6Parkinson Disease 4, Autosomal Dominant Lewy Body 5Esophageal Squamous Cell Carcinoma 5Adenocarcinoma of Lung 5Sarcoma 4Salivary Gland Neoplasms 4Oropharyngeal Neoplasms 4Laryngeal Diseases 4Precancerous Conditions 3Hypopharyngeal Neoplasms 3

Interventions

selpercatinib 2Sorafenib 2vandetanib 1temsirolimus 1pralsetinib 1pembrolizumab 1lenvatinib 1cabozantinib 1Vitamin B 12 1Thyrotropin-Releasing Hormone 1Technetium Tc 99m Sestamibi 1Pemetrexed 1Panobinostat 1NAc-Sar-Gly-Val-(d-allo-Ile)-Thr-Nva-Ile-Arg-ProNEt 1Metformin 1Folic Acid 1Fluorescein 1Cisplatin 1Cetuximab 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Thyroid Diseases × Cetuximab × Clear all
NCT01057589 2013-09-18

A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Eli Lilly and Company

Phase 2 Completed
66 enrolled 11 charts
Head & Neck

Head and Neck Neoplasms, Laryngeal Diseases, Thyroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡